Global Patent Index - EP 4167989 A4

EP 4167989 A4 20240703 - COMPOSITION FOR TREATING VIRAL INFECTIONS

Title (en)

COMPOSITION FOR TREATING VIRAL INFECTIONS

Title (de)

ZUSAMMENSETZUNG ZUR BEHANDLUNG VON VIRUSINFEKTIONEN

Title (fr)

COMPOSITION POUR LE TRAITEMENT D'INFECTIONS VIRALES

Publication

EP 4167989 A4 20240703 (EN)

Application

EP 21826360 A 20210525

Priority

  • US 202063041471 P 20200619
  • US 2021034002 W 20210525

Abstract (en)

[origin: WO2021257252A1] A composition of a therapeutically effective amount of luteolin, quercetin, kaempferol, and vitamin C, and a therapeutically acceptable carrier for preventing or treating viral infections. A method of preventing or treating a viral infection in a subject by administering the composition to a subject. The viral infection may be a coronavirus infection.

IPC 8 full level

A61K 31/35 (2006.01); A61K 31/352 (2006.01); A61K 31/375 (2006.01); A61P 31/12 (2006.01); A61P 31/14 (2006.01); A61P 31/16 (2006.01); A61P 31/22 (2006.01)

CPC (source: EP US)

A61K 31/352 (2013.01 - EP US); A61K 31/375 (2013.01 - EP US); A61P 31/12 (2017.12 - EP); A61P 31/14 (2017.12 - EP US); A61P 31/16 (2017.12 - EP); A61P 31/22 (2017.12 - EP); Y02A 50/30 (2017.12 - EP)

C-Set (source: EP)

  1. A61K 31/352 + A61K 2300/00
  2. A61K 31/375 + A61K 2300/00

Citation (search report)

  • [Y] WO 2013078184 A2 20130530 - QUERCEGEN PHARMACEUTICALS LLC [US]
  • [Y] CN 109988104 A 20190709 - INST MATERIA MEDICA CAMS
  • [Y] HASLBERGER ALEXANDER ET AL: "Mechanisms of selected functional foods against viral infections with a view on COVID-19: Mini review", FUNCTIONAL FOODS IN HEALTH AND DISEASE, vol. 10, no. 5, 11 May 2020 (2020-05-11), pages 195, XP055784899, ISSN: 2378-7007, Retrieved from the Internet <URL:https://www.ffhdj.com/index.php/ffhd/article/viewFile/707/1259> DOI: 10.31989/ffhd.v10i5.707
  • [Y] IQBAL KHAN RASHID ET AL: "Plant Derived Antiviral Products for Potential Treatment of COVID-19: A Review", PHYTON, vol. 89, no. 3, 1 January 2020 (2020-01-01), pages 438 - 452, XP055881064, ISSN: 1851-5657, DOI: 10.32604/phyton.2020.010972
  • [Y] BEN-SHABAT SHIMON ET AL: "Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies", DRUG DELIVERY AND TRANSLATIONAL RESEARCH, SPRINGER, GERMANY, vol. 10, no. 2, 1 December 2019 (2019-12-01), pages 354 - 367, XP037069261, ISSN: 2190-393X, [retrieved on 20191201], DOI: 10.1007/S13346-019-00691-6
  • [Y] AL MUQARRABUN L M R ET AL: "Medicinal uses, phytochemistry and pharmacology ofPongamia pinnata(L.) Pierre: A review", JOURNAL OF ETHNOPHARMACOLOGY, ELSEVIER IRELAND LTD, IE, vol. 150, no. 2, 7 September 2013 (2013-09-07), pages 395 - 420, XP028765931, ISSN: 0378-8741, DOI: 10.1016/J.JEP.2013.08.041
  • [Y] KHAERUNNISA SITI ET AL: "Potential Inhibitor of COVID-19 Main Protease (M<sup>pro</sup>) From Several Medicinal Plant Compounds by Molecular Docking Study", PREPRINT, vol. 1, 13 March 2020 (2020-03-13), pages 1 - 14, XP055867496, DOI: 10.20944/preprints202003.0226.v1
  • [Y] RUBEN MANUEL LUCIANO COLUNGA BIANCATELLI: "The antiviral properties of vitamin C", EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, vol. 18, no. 2, 23 December 2019 (2019-12-23), GB, pages 99 - 101, XP093160977, ISSN: 1478-7210, DOI: 10.1080/14787210.2020.1706483
  • [Y] CHENG RICHARD: "Successful High-Dose Vitamin C Treatment of Patients with Serious and Critical COV1D-19 Infection", ORTHOMOLECULAR MEDICINE NEWS SERVICE, 18 March 2020 (2020-03-18), pages 1 - 3, XP055864701, Retrieved from the Internet <URL:https://www.aima.net.au/wp-content/uploads/2020/06/Successful-High-Dose-Vitamin-C-Treatment-of-Patients-with-Serious-and-Critical-COVID-19-Infection.pdf>
  • See references of WO 2021257252A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

WO 2021257252 A1 20211223; BR 112022023637 A2 20221220; EP 4167989 A1 20230426; EP 4167989 A4 20240703; US 2023089090 A1 20230323

DOCDB simple family (application)

US 2021034002 W 20210525; BR 112022023637 A 20210525; EP 21826360 A 20210525; US 202117922676 A 20210525